Clinical trials haven’t changed much in decades. These industry leaders show us why it’s time for disruption – and how to make it happen. Spencer Health Solutions is proud to present the Voices of Disruption.
Voices of Disruption is a discussion among patients and pharma industry leaders about obstacles to change in clinical trials produced by Spencer Health Solutions.
Three years in the market, the spencer Direct-to-Patient platform is consistently demonstrating a new standard of greater than 95% adherence among chronically-ill patients.
We continue the conversation with Darcy Forman of Firma Clinical Research in part 2 on the People Always, Patients Sometimes podcast.
On today's People Always, Patients Sometimes podcast we’ll hear from Ken Getz, founder and chairman of CISCRP.
Patients now have more input in the drug development process and more opportunities to share their experiences to help get promising therapies to market.
We created an infographic that really brings home the dramatic impact that non-adherence can have on a clinical trial.
Eye for Pharma hosted a webinar moderated by CEO Paul Simms with the topic Patient-Preferred Trials. Twitter curation by @GetSocialHealth
Easing patients’ daily workload by automating how medications are dispensed and health data is collected are two key leverage points for digital health solutions that can lead to better health outcomes.
The era of siteless clinical trials for drug development is here. Also known as virtual, remote and digital trials, siteless trials build on the “direct-to-patient” trend in clinical trial design.